Loading…
Should ebselen be considered for the treatment of mercury intoxication? A minireview
Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg , Hg and Hg ) and organic forms (chiefly CH Hg or MeHg ). The main route of human, mammals and bird exposure occurs predatory fish ingestion. Occupational exposure to Hg (and Hg ) can also occur; furthermore, in gold...
Saved in:
Published in: | Toxicology mechanisms and methods 2024, Vol.34 (1), p.1-12 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453 |
---|---|
cites | cdi_FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453 |
container_end_page | 12 |
container_issue | 1 |
container_start_page | 1 |
container_title | Toxicology mechanisms and methods |
container_volume | 34 |
creator | Barbosa, Nilda V Aschner, Michael Tinkov, Alexey A Farina, Marcelo Rocha, João Batista Teixeira da |
description | Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg
, Hg
and Hg
) and organic forms (chiefly CH
Hg
or MeHg
). The main route of human, mammals and bird exposure occurs
predatory fish ingestion. Occupational exposure to Hg
(and Hg
) can also occur; furthermore, in gold mining areas the exposure to inorganic Hg can also be high. The toxicity of electrophilic forms of Hg (E
Hg) is mediated by disruption of thiol (-SH)- or selenol (-SeH)-containing proteins. The therapeutic approaches to treat methylmercury (MeHg
), Hg
and Hg
are limited. Here we discuss the potential use of ebselen as a potential therapeutic agent to lower the body burden of Hg in man. Ebselen is a safe drug for humans and has been tested in clinical trials (for instance, brain ischemia, noise-induce hearing loss, diabetes complications, bipolar disorders) at doses varying from 400 to 3600 mg per day. Two clinical trials with ebselen in moderate and severe COVID are also approved. Ebselen can be metabolized to an intermediate with -SeH (selenol) functional group, which has a greater affinity to electrophilic Hg (E
Hg) forms than the available thiol-containing therapeutic agents. Accordingly, as observed
and rodent models
Ebselen exhibited protective effects against MeHg
, indicating its potential as a therapeutic agent to treat MeHg
overexposure. The combined use of ebselen with thiol-containing molecules (e.g. N-acetylcysteine and enaramide)) is also commented, because they can have synergistic protective effects against MeHg
. |
doi_str_mv | 10.1080/15376516.2023.2258958 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10841883</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2867148875</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453</originalsourceid><addsrcrecordid>eNpVUclOwzAQtRCIluUTQD5ySbHj2HFPCCE2qRIH4Gw59pgaJXGxE5a_JxGhgsvMaJb3nuYhdELJghJJzilnpeBULHKSs0Wec7nkcgfNx34meF7sbmsqZuggpVdCqKQF3UczVpaMMs7m6OlxHfraYqgS1NDiCrAJbfIWIljsQsTdGnAXQXcNtB0ODjcQTR-_sG-78OmN7nxoL_AlbnzrI7x7-DhCe07XCY6nfIieb66fru6y1cPt_dXlKjNM8C5bEkeqXC5tKa2sNNWUC82NsByccbQAPWxUGixoKSq3ZLakhS4rnjtZuoKzQ3Txg7vpqwasGQRGXatN9I2OXypor_5PWr9WL-FdDR8sqJRsQDibEGJ46yF1qvHJQF3rFkKfVC7FwCllOZLxn1UTQ0oR3JaHkhFwCJMlarRETZYMd6d_RW6vfj1g32TRib8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2867148875</pqid></control><display><type>article</type><title>Should ebselen be considered for the treatment of mercury intoxication? A minireview</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Barbosa, Nilda V ; Aschner, Michael ; Tinkov, Alexey A ; Farina, Marcelo ; Rocha, João Batista Teixeira da</creator><creatorcontrib>Barbosa, Nilda V ; Aschner, Michael ; Tinkov, Alexey A ; Farina, Marcelo ; Rocha, João Batista Teixeira da</creatorcontrib><description>Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg
, Hg
and Hg
) and organic forms (chiefly CH
Hg
or MeHg
). The main route of human, mammals and bird exposure occurs
predatory fish ingestion. Occupational exposure to Hg
(and Hg
) can also occur; furthermore, in gold mining areas the exposure to inorganic Hg can also be high. The toxicity of electrophilic forms of Hg (E
Hg) is mediated by disruption of thiol (-SH)- or selenol (-SeH)-containing proteins. The therapeutic approaches to treat methylmercury (MeHg
), Hg
and Hg
are limited. Here we discuss the potential use of ebselen as a potential therapeutic agent to lower the body burden of Hg in man. Ebselen is a safe drug for humans and has been tested in clinical trials (for instance, brain ischemia, noise-induce hearing loss, diabetes complications, bipolar disorders) at doses varying from 400 to 3600 mg per day. Two clinical trials with ebselen in moderate and severe COVID are also approved. Ebselen can be metabolized to an intermediate with -SeH (selenol) functional group, which has a greater affinity to electrophilic Hg (E
Hg) forms than the available thiol-containing therapeutic agents. Accordingly, as observed
and rodent models
Ebselen exhibited protective effects against MeHg
, indicating its potential as a therapeutic agent to treat MeHg
overexposure. The combined use of ebselen with thiol-containing molecules (e.g. N-acetylcysteine and enaramide)) is also commented, because they can have synergistic protective effects against MeHg
.</description><identifier>ISSN: 1537-6516</identifier><identifier>EISSN: 1537-6524</identifier><identifier>DOI: 10.1080/15376516.2023.2258958</identifier><identifier>PMID: 37731353</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Azoles - therapeutic use ; Humans ; Mammals - metabolism ; Mercury - toxicity ; Methylmercury Compounds - metabolism ; Methylmercury Compounds - toxicity ; Sulfhydryl Compounds</subject><ispartof>Toxicology mechanisms and methods, 2024, Vol.34 (1), p.1-12</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453</citedby><cites>FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37731353$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barbosa, Nilda V</creatorcontrib><creatorcontrib>Aschner, Michael</creatorcontrib><creatorcontrib>Tinkov, Alexey A</creatorcontrib><creatorcontrib>Farina, Marcelo</creatorcontrib><creatorcontrib>Rocha, João Batista Teixeira da</creatorcontrib><title>Should ebselen be considered for the treatment of mercury intoxication? A minireview</title><title>Toxicology mechanisms and methods</title><addtitle>Toxicol Mech Methods</addtitle><description>Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg
, Hg
and Hg
) and organic forms (chiefly CH
Hg
or MeHg
). The main route of human, mammals and bird exposure occurs
predatory fish ingestion. Occupational exposure to Hg
(and Hg
) can also occur; furthermore, in gold mining areas the exposure to inorganic Hg can also be high. The toxicity of electrophilic forms of Hg (E
Hg) is mediated by disruption of thiol (-SH)- or selenol (-SeH)-containing proteins. The therapeutic approaches to treat methylmercury (MeHg
), Hg
and Hg
are limited. Here we discuss the potential use of ebselen as a potential therapeutic agent to lower the body burden of Hg in man. Ebselen is a safe drug for humans and has been tested in clinical trials (for instance, brain ischemia, noise-induce hearing loss, diabetes complications, bipolar disorders) at doses varying from 400 to 3600 mg per day. Two clinical trials with ebselen in moderate and severe COVID are also approved. Ebselen can be metabolized to an intermediate with -SeH (selenol) functional group, which has a greater affinity to electrophilic Hg (E
Hg) forms than the available thiol-containing therapeutic agents. Accordingly, as observed
and rodent models
Ebselen exhibited protective effects against MeHg
, indicating its potential as a therapeutic agent to treat MeHg
overexposure. The combined use of ebselen with thiol-containing molecules (e.g. N-acetylcysteine and enaramide)) is also commented, because they can have synergistic protective effects against MeHg
.</description><subject>Animals</subject><subject>Azoles - therapeutic use</subject><subject>Humans</subject><subject>Mammals - metabolism</subject><subject>Mercury - toxicity</subject><subject>Methylmercury Compounds - metabolism</subject><subject>Methylmercury Compounds - toxicity</subject><subject>Sulfhydryl Compounds</subject><issn>1537-6516</issn><issn>1537-6524</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNpVUclOwzAQtRCIluUTQD5ySbHj2HFPCCE2qRIH4Gw59pgaJXGxE5a_JxGhgsvMaJb3nuYhdELJghJJzilnpeBULHKSs0Wec7nkcgfNx34meF7sbmsqZuggpVdCqKQF3UczVpaMMs7m6OlxHfraYqgS1NDiCrAJbfIWIljsQsTdGnAXQXcNtB0ODjcQTR-_sG-78OmN7nxoL_AlbnzrI7x7-DhCe07XCY6nfIieb66fru6y1cPt_dXlKjNM8C5bEkeqXC5tKa2sNNWUC82NsByccbQAPWxUGixoKSq3ZLakhS4rnjtZuoKzQ3Txg7vpqwasGQRGXatN9I2OXypor_5PWr9WL-FdDR8sqJRsQDibEGJ46yF1qvHJQF3rFkKfVC7FwCllOZLxn1UTQ0oR3JaHkhFwCJMlarRETZYMd6d_RW6vfj1g32TRib8</recordid><startdate>2024</startdate><enddate>2024</enddate><creator>Barbosa, Nilda V</creator><creator>Aschner, Michael</creator><creator>Tinkov, Alexey A</creator><creator>Farina, Marcelo</creator><creator>Rocha, João Batista Teixeira da</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2024</creationdate><title>Should ebselen be considered for the treatment of mercury intoxication? A minireview</title><author>Barbosa, Nilda V ; Aschner, Michael ; Tinkov, Alexey A ; Farina, Marcelo ; Rocha, João Batista Teixeira da</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Azoles - therapeutic use</topic><topic>Humans</topic><topic>Mammals - metabolism</topic><topic>Mercury - toxicity</topic><topic>Methylmercury Compounds - metabolism</topic><topic>Methylmercury Compounds - toxicity</topic><topic>Sulfhydryl Compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barbosa, Nilda V</creatorcontrib><creatorcontrib>Aschner, Michael</creatorcontrib><creatorcontrib>Tinkov, Alexey A</creatorcontrib><creatorcontrib>Farina, Marcelo</creatorcontrib><creatorcontrib>Rocha, João Batista Teixeira da</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Toxicology mechanisms and methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barbosa, Nilda V</au><au>Aschner, Michael</au><au>Tinkov, Alexey A</au><au>Farina, Marcelo</au><au>Rocha, João Batista Teixeira da</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Should ebselen be considered for the treatment of mercury intoxication? A minireview</atitle><jtitle>Toxicology mechanisms and methods</jtitle><addtitle>Toxicol Mech Methods</addtitle><date>2024</date><risdate>2024</risdate><volume>34</volume><issue>1</issue><spage>1</spage><epage>12</epage><pages>1-12</pages><issn>1537-6516</issn><eissn>1537-6524</eissn><abstract>Mercury is a ubiquitous environmental contaminant and can be found in inorganic (Hg
, Hg
and Hg
) and organic forms (chiefly CH
Hg
or MeHg
). The main route of human, mammals and bird exposure occurs
predatory fish ingestion. Occupational exposure to Hg
(and Hg
) can also occur; furthermore, in gold mining areas the exposure to inorganic Hg can also be high. The toxicity of electrophilic forms of Hg (E
Hg) is mediated by disruption of thiol (-SH)- or selenol (-SeH)-containing proteins. The therapeutic approaches to treat methylmercury (MeHg
), Hg
and Hg
are limited. Here we discuss the potential use of ebselen as a potential therapeutic agent to lower the body burden of Hg in man. Ebselen is a safe drug for humans and has been tested in clinical trials (for instance, brain ischemia, noise-induce hearing loss, diabetes complications, bipolar disorders) at doses varying from 400 to 3600 mg per day. Two clinical trials with ebselen in moderate and severe COVID are also approved. Ebselen can be metabolized to an intermediate with -SeH (selenol) functional group, which has a greater affinity to electrophilic Hg (E
Hg) forms than the available thiol-containing therapeutic agents. Accordingly, as observed
and rodent models
Ebselen exhibited protective effects against MeHg
, indicating its potential as a therapeutic agent to treat MeHg
overexposure. The combined use of ebselen with thiol-containing molecules (e.g. N-acetylcysteine and enaramide)) is also commented, because they can have synergistic protective effects against MeHg
.</abstract><cop>England</cop><pmid>37731353</pmid><doi>10.1080/15376516.2023.2258958</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1537-6516 |
ispartof | Toxicology mechanisms and methods, 2024, Vol.34 (1), p.1-12 |
issn | 1537-6516 1537-6524 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10841883 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | Animals Azoles - therapeutic use Humans Mammals - metabolism Mercury - toxicity Methylmercury Compounds - metabolism Methylmercury Compounds - toxicity Sulfhydryl Compounds |
title | Should ebselen be considered for the treatment of mercury intoxication? A minireview |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A03%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Should%20ebselen%20be%20considered%20for%20the%20treatment%20of%20mercury%20intoxication?%20A%20minireview&rft.jtitle=Toxicology%20mechanisms%20and%20methods&rft.au=Barbosa,%20Nilda%20V&rft.date=2024&rft.volume=34&rft.issue=1&rft.spage=1&rft.epage=12&rft.pages=1-12&rft.issn=1537-6516&rft.eissn=1537-6524&rft_id=info:doi/10.1080/15376516.2023.2258958&rft_dat=%3Cproquest_pubme%3E2867148875%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-90f0b289d78d8ba1a156a5c6d5efcf14ea90fbaedea86bf93d714a7b52f87f453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2867148875&rft_id=info:pmid/37731353&rfr_iscdi=true |